tirz
£150.00
Tirzepatide is a dual GIP and GLP-1 receptor agonist that has been widely studied for its effects on appetite regulation, blood glucose control and body-weight management.
Key Features
• Dual GIP & GLP-1 receptor activity
• Extensively studied in metabolic and weight-management research
• Investigated for appetite and satiety regulation
• Supplied in a convenient vial format
Important: Tirzepatide is a prescription medicine when intended for human use. Products sold for research purposes should not be marketed or supplied for self-administration or human consumption.